Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice

類似資料

• The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice
  著者:: May, Meghan, 等
  出版事項: (2019)
• Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice
  著者:: Rostama, Bahman, 等
  出版事項: (2020)
• A novel role for dopamine signaling in the pathogenesis of bone loss from the atypical antipsychotic drug risperidone in female mice
  著者:: Motyl, Katherine J., 等
  出版事項: (2017)
• Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain
  著者:: Motyl, Katherine J., 等
  出版事項: (2011)
• Notch2 and Proteomic Signatures in Mouse Neointimal Lesion Formation
  著者:: Peterson, Sarah M., 等
  出版事項: (2018)